Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacokinetics of 4′-cyano-2′-deoxyguanosine, a novel nucleoside analog inhibitor of the resistant hepatitis B virus, in a rat model of chronic kidney disease

Journal of Infection and Chemotherapy(2020)10.1016/j.jiac.2020.12.014Source: DataRank Database

Pharmacokinetics of 4′-cyano-2′-deoxyguanosine, a novel nucleoside analog inhibitor of the resistant hepatitis B virus, in a rat model of chronic kidney disease is a research paper published in Journal of Infection and Chemotherapy (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.00)OA: greenTopics (30)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Kazuaki Taguchi ORCID,Shuhei Imoto,Keishi Yamasaki ORCID,Hiroaki Mitsuya ORCID,Masaki Otagiri ORCID

Live enrichment

PubMed:33386259 PMC:PMC9713688 OpenAlex:https://openalex.org/W3116420000

Japan Agency for Medical Research and Development

Grant: JP20fk0310113

Japan Agency for Medical Research and Development

Grant: HBVA181T/N236T

Japan Agency for Medical Research and Development

Grant: HBVL180M/S202G/M204V

Intramural NIH HHS

Grant: ZIA BC011486

Japan Agency for Medical Research and Development

FWCI

0.00

Citation Percentile

0.2%

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9713688

publisherhttps://api.elsevier.com/content/article/PII:S1341321X20304499?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1341321X20304499?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jiac.2020.12.014

Fields of Study

Hepatitis B Virus StudiesHIV/AIDS drug development and treatmentBiochemical and Molecular Research

MeSH Terms

AnimalsDeoxyguanosineHepatitis B virusNucleosidesRatsRenal Insufficiency, Chronic

Keywords

PharmacokineticsRenal functionMedicinePharmacologyKidney diseaseKidneyDeoxyguanosineNucleosideCreatinineOral administrationNucleoside analogueNephrotoxicityInternal medicineDistribution (mathematics)EndocrinologyChemistryBiochemistryHepatitis BDispositionChronic Kidney DiseaseNucleoside Analog

Sustainable Development Goals

SDG 0: Good health and well-being